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Summary: A method for the determination of creatinine in human serum by isotope dilution-mass spectrometry
is described. The analytical procedure comprises the following Steps:
(1) Addition of [13C,15N2]creatinine to the serum sample;
(2) ion exchange chromatography on the cation exchange resin AG 50W-X2;
(3) formation of the trimethylsilyl derivative;
(4) gas liquid chromatography-mass spectrometry (GC-MS); selected ion monitoring (SIM) at the m/z-values
329 and 332;
(5) calculation of the amount of creatinine in the serum sample from the isotope ratio, äs measured by GC-
MS.
[13C,15N2]Creatinine was prepared by chemical synthesis. The substance is then used äs internal Standard for
the measurement of creatinine in serum samples.
The imprecision of the method was in the ränge from 0.35 to 1.05% (coefficient of Variation) äs determined
by repetitive measurements of creatinine in 13 different control sera on different pccasions. The lower limit
of detection of the mass spectrometer in the selected ion monitoring mode is about 0.5 ng creatinine with a
signal to noise ratio of 3: l
The accuracy of the method is achieved by the use of the isotope dilution principle in combination with GC-
MS. In view of the high specificity and exact control of recovery, the procedure for the measurement of
creatinine in human serum, äs described here, may be considered äs a definitive method in clinical chemistry.
Bestimmung von Kreatinin im menschlichen Serum mit Hilfe der massenspektrometrischen Isotopenverdünnungs-
analyse
Definitive Methoden in der Klinischen .Chemie, IV
Zusammenfassung: Es wird eine massenspektrometrische Isotopenverdünnungsmethode zur Bestimmung von
Kreatinin in menschlichem Serum beschrieben. Das Analysenverfahren umfaßt folgende Schritte:
(1) Zugabe von [13C,15N2]Kreatinin zu der Serumprobe;
(2) lonenaustauschchromatographie an dem Kationenaustauscher AG 50W-X2;
(3) Bildung des Trimethylsilylderivates von Kreatinin;
(4) Gaschromatographie-Massenspektrometrie (GC-MS), massenspezifische Detektion bei den m/z-Werten
329 und 332;
(5) Berechnung der Menge an Kreatinin in der Serumprobe aus dem massenspektrometrisch ermittelten
Isotopenverhältnis.
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[nCl5N,]Kreatinin wurde zunächst durch chemische Synthese hergestellt. Die Substanz wurde dann als
interner Standard zur Messung von Kreatinin in Serumproben verwendet.
Die Impräzision der Methode lag im Bereich von 0,35 bis 1,05% (Variationskoeffizient); dies wurde
durch Mehrfachanalyse von 13 verschiedenen Kontrollseren an verschiedenen Tagen ermittelt. Die untere
Nachweisgrenze des Massenspektrometers bei der massenspezifischen Detektion liegt bei etwa 0,5 ng Kreatinin
bei einem Signal-zu-Rausch-Verhältnis von 3:1. · f
Die Richtigkeit der Methode wird durch die Anwendung des Isotopenverdiinnungsprinzips in Kombination
mit der Gaschromatographie-Massenspektrometrie erreicht. In Anbetracht der hohen Spezifität und der
exakten Kontrolle der Wiederfindung kann das hier beschriebene Verfahren zur Bestimmung von Kreatinin
in menschlichem Serum als definitive Methode in der Klinischen Chemie angesehen werden.
Introduction
The concentration of creatinine in human serum is one
of the most frequently determined clinical chemical
Parameters. The increase of this endproduct of metab-
olism in blood directly reflects the degree of in-
sufficiency of glomerular filtration in the kidneys. For
a long time the only technique for the measurement
of creatinine hi human body fluids was the colour
reaction with picric acid (l, 2). Since this reaction is
known to be sensitive to interference from many
drugs, additional Steps of Chromatographie pre-
purification have been introduced into the analytical
procedure (3, 4, 5). During recent years enzymatic
reactions (6 — 9), high performance liquid chromato-
graphy (10-17) and GC-MS (18-20) have been
proposed for the measurement of creatinine.
Significant differences are observed when the results
obtained with various routine methods for the same
serum are compared (21). This is also apparent from
the results of collaborative surveys of many quality
control organisations. Since, at present, there exist no
reliable criteria to decide what method would yield
the most accurate results, it is necessary to apply
several method-dependent target values for the eval-
uation of the collaborative surveys. In order to
overcome this unsatisfactory Situation it appeared
necessary to develop a reference and definitive method
technology for the measurement of creatinine. In the
present investigation a definitive method for the
determination of creatinine in human serum is de-
scribed which is based on the principle of istope
dilution-mass spectrometry (ID-MS).
ftrinciple of the Method
Serum samples, containing unknown amounts of cre-
atinine, are equilibrated with definite amounts of
isotopically labelled [13C,15N2]creatinine. The sub-
stances are then isolated from the biological material
by the use of an ion exchange resin and converted to
the trirhethylsilyl derivatives. The ratio of non-labelled
to labelled creatinine is measured by combined gas
chromatography-mass spectrometry. The isotope
ratios, measured after processing the serum samples,
are compared with those obtained from Standards
containing known amounts of labelled and noii-
labelled creatinine. The unknown amounts of cre-
atinine are calculated fröm the isotope ratios
determined in the serum samples and Standards.
Material and Procedure
Reagents
Creatinine (purity 99.8%) is a Standard reference material
(SRM 914, National Bureau of Standards, Washington, USA).
[13C,15N2]Creatinme is prepared by chemical synthesis äs de-
scribed below. pC,15NJCyanamide (91.6 atom % 13C; 99.5
atom % 1SN) is obtained from Amersham Buchler,
Braunschweig, FRG. Sarcosine ethyl ester hydrochloride is
a product of Fluka, Basel, Switzerland. Tris[hydroxymethyl]
aminomethane is supplied by Merck, Dannstädt, FRG. Ion
exchange resin, AG 50WOC2, 200-400 mesh, hydrogen form,
is obtained from Biorad, München, FRG. The resin is washed
with 2 mol/1 ammonia und distilled water. The material is then
filled into small glass columns (200 4 mm) to a height of 4 cm.
N-Methyl-N-trimethylsüyl-trifluoroacetic amide (MSTFA) is
supplied by Macherey & Nagel, Düren, FRG. Dried pyridine
(Merck, Darmstadt, FRG) is stored over molecular sieve 4Ä
(Merck). All solvents are of analytical grade or distilled prior
to use.
Synthesis of [13C,lsN2]Creatinine
The preparation of labelled creatinine is based on a chemicai
reaction which has been described by Äbderhalden & Sickel
(22). 42mg [13C,15NjCyanamide (dried in a desiccator) is
dissolved in 160 triethylamine which was stored Over mol-
ecular sieve 4Ä. 160mg Sarcosine ethyl ester hydrochloride
(dried in a desiccator) is added. The mixture is stirred with a
magnetic agitator overnight at 80°C. the triethylamine is
evaporated in a stream of nitrogen at 60 °C and the residue is
dried under reduced pressure. The crude reaction product is
dissolved in l ml 0.05 mol/1 ammonia and chromatographed on
an RP-8 column (25 2.5cm, Lobar, 40-63 , Merck,
Darmstadt, FRG) with 0.05 mol/1 ammonia äs elüant. The
isptopically labelled creatinine is eluted after about 80 ml. the
fractions eontaining the labelled substanee are collected and
the solvent is evaporated under reduced pressure. Further
purification is achieved by preparative high performance liquid
chromatography (HPLC). The labelled creatinine is dissolved
and chromatographed in a 0.01 mol/1 tris[hydroxyriiethyl]
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aminomethane/hydrochloric acid buffer (pH 7.6). The eluant is
pumped at 2 ml/min through the column. The creatinine-
containing fractions are collected and the solvent is removed
ander reduced pressure. Final purification is carried out
by recrystallisation from ethanol at 0°C. 41 mg of [13C,15NJ
creatinine corresponding to 36% of the theoreticai yield is
obtained s final product. The purity of the substance was
checked by glass capillary column gas chromatography of the
trimethylsilyl derivative on a 30 m fused silica column coated
with SE-52. The identity of the substance was verified by
combined gas chromatography-mass spectrometry (GC-MS) of
the trimethylsilyl derivative, which gave the mass spectrum
shown in figure 1.
Glassware
For the preparation of the creatinine Standard solution a 100
ml Volumetrie fiask is calibrated by filling k to the calibration
mark with water at 20°C and weighing the contents. For the
sampling of serum s well s for dispensing the non-labeiled
Standard solution an electronically automated pipettor
(Microlab P, Hamilton, Bonaduz, Switzerland) equipped with
a gas-tight 2.5 ml syringe is calibrated by weighing defmite
amounts of water at 20°C. For pipetting of the P3C,15NJ
creatinine solution a 50 μΐ-syringe (SGE, Melbourne, Australia)
equipped with a repeating adaptor which is adjusted to 25 μΐ is
used. The precision of the pipetting procedure using the syringe
and the Hamilton pipettor is determined by weighing ap-
propriate samples of water ten times a 120 °C. The water samples
are weighed in small plastic vials which are closed immediately
after dosage in order to avoid any loss of the water due to
evaporation during the weighing procedure. The imprecision of
the Hamilton pipettor is about 0.03% (coefficient of Variation,
CV) and that of the 50 ul-syringe about 0.15%.
Weighing Procedure
The creatinine certified reference material, the isotopically
labelled creatinine s well s the water samples for calibrating
the 50 μΐ-syringe and the Hamilton pipettor are weighed with
an electronically automated balance (model 4503, Sartorius,
G ttingen, FRG). The Volumetrie flask is calibrated with the
use of a mechanical balance (model 2432, Sartorius, G ttingen,
FRG). The accuracy of the balances is ascertained by the use
of officially calibrated test weights.
Instruments and Settings
For preparative HPLC a stainless steel column (25 χ 0.8 cm,
Knauer, Berlin, FRG) is packed with Lichrosorb RP-8, 5 μπι
(Merck, Darmstadt, FRG). Chromatography is carried out with
a constant flow pump (model 600) and a UV-detector (model
SP-4) which is set to 235 nm; both Instruments are from
Gynkotek, M nchen, FRG. For gas liquid chromatography a
gas Chromatograph model 4100 (Carlo Erba, Milano, Italy) is
used. The Instrument is equipped with a fused silica capillary
column, 30 m χ 0.32 mm, coated with a film of 0.25 μιη SE-
52 (J& W Scientiflc, Rancho Cordova, USA). The temperature
of the column is programmed from 140 to 180°C with a rate
of 2°C/min. Nitrogen is used s carrier gas at an inlet pressure
of 70 kPa. Substances are injected into a split inlet device
(Gerstel, M lheim, FRG) which is kept at 240°C. The split
ratio is set to a value of about 1:10.
%
For GC-MS a combined gas chrornatograph-mass spectrometer
model 1020 (Finnigan ΜΑΤ, Bremen, FRG) is used. The
conditions for gas liquid chromatography are the same s
described above with the exception that helium is used s carrier
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Fig. 1. Mass spectrum of the trimethylsilyl derivative of creatinine (upper panel) and of [l3C,l5N2]creatinine (lower panel). For
conditions of recording see Instruments and Settings.
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via a divcrt valve to the mass spectrometer. During the first
140s of chromatography the valvc is opened in order to suck
off solvcnts and rcagcnts thereby protecting the ion source of
the mass spectrometer from an exccss of substances.
Electron impact ionisation is used for mass spectrometry. The
ionisation energy is 70 eV. With the selected ion recording mode
the quadrupole filier of the mass spectrometer is adjusted to a
resolution of about 400 (10% valley definition). For the re-
cording of mass spectra the Instrument is scanned in the r nge
from m/z 50 lo 400; in this case the resolution is set to approxi-
mately 800.
Preparation of Standard Solutions
A specified amount of certified reference creatinine (purity
99.8%, estimated inaccuracy 0.1%) in the r nge of 1.45 to
1.55mg (e.g. 1.526 mg) is dissolved in 100ml distilled water
using the calibrated Volumetrie flask at 20°C. The weight is
corrected with respect to the impurities of the reference material
by the factor 0.998 and according to the calibrated volume of
the flask by multiplying by 0.99689, thus yielding a final
concentration of 15.182 μg/ml. A new Standard solution is
prepared for each occasion.
For the preparation of the [13C,15N2]creatinine Standard sol-
ution about 3 mg of the labelled compound are dissolved in
25 ml distilled water. The solution is stored in portions of 5 ml
at — 20°C. One portion, which is used s the labelled working
solution, is kept in a refrigerator at 4°C; this is stable for at
least 3 weeks. The material is equilibrated to 20°C prior to use.
Preparation of Standards
For the calibration of the creatinine measurement three Stan-
dards with different amounts of creatinine are prepared for each
batch of analyses:
Standard i contains a mixture of 25 μΐ of the labelled creatinine
and 150 μΐ of the non-labelled creatinine solution,
Standard 2 consists of 25 μΐ labelled and 200 μΐ non-labelled
working solution and
Standard 3 is a mixture of 25 μΐ labelled and 250 μΐ non-labelled
creatinine Standard solution. The labelled creatinine is pipetted
with the 50 μΐ-syringe and the non-labelled substance is
dispensed with the Hamilton Microlab P pipettor.
Each of the three Standards is prepared in triplicate. The exact
volumes of the non-labelled Standard solution, s measured by
calibrating the Hamilton pipettor, are 150.252 μΐ ± 0.065 μΐ
(Standard deviation, s.d.), 200.882 μΐ ± 0.078 μΐ (s.d.) and
250.976 ± 0.055 μΐ (s.d.), respectively. Thereby it is calculated
that Standard l contains 2.2811 μ& Standard 2 3.0498 μg and
Standard 3 3.8103 μg of the creatinine reference material. It
should be noted that it is not necessary to know accurately the
amount of the labelled creatinine. However, it must be carefully
checked that the Standards and samples contain the same
amount of the labelled substance. This is achieved by using the
same syringe equipped with the repeating adaptor for the
addition of the labelled substance to Standards and serum
samples. The Standards are prepared in small tapered lest tubes
(total volume about 2ml) with a ground glass Stopper. The
Standard mixtures are evaporated to dryness in a streara of
nitrogen at 80°C.
Sample Preparation
The approximate concentration of creatinine in the serum
samples to be investigated is first estimated by the use of a
routine method. Then aliquots of the serum containing about
3 μ§ creatinine are sampled with the Hamilton pipettor. A half
volume (with respect to the amount of serum) of hydrochloric
acid (0.1 mol/l) is added and the samples are diluted with
distilled water to a final volume of 0.5ml by the use of the
electronically automated pipettor. 25 μΐ of the labelled creatinine
solution is added and the mixture is equilibrated by gently
shaking it at room temperature for 2 h. Then the diluted sefum
samples are transferred to the ion exchange columns. The
columns are first washed with 2.5ml djst led water in two
portions (0.5 and 2.0 ml) and then with 0.75 ml 2 mol/l ammonia
solution. Creatinine s well s the.labelled compound are eluted
by addition of a further 0.5 ml of ammonia (2 mol/l). The
samples are collected in small tapered test tubes (total volume
about 2ml) with a ground glass Stopper and evaporated to
dryness in a stream of nitrogen at 80 °C.
Derivative Formation
The dry residues of Standards and samples are reacted with
30 μΐ of a mixture (l: l, by vol.) of MSTFA and pyridine (dried
over molecular sieve 4 ). The reaction is carried out at 60°C
within 40 min.
Selected Ion Recording
Aliquots of about l μΐ of the reaction mixture are injected into
the split inlet System and chrofnatographed on the SE-52 column
which is coupled to the mass spectrometer. For the selected ion
recording technique the quadrupole filter of the Instrument is
scanned over two small mass ranges which are set from — 0.25
to + 0.25 mass units from the peak center of the molecular ion
of the trimethylsilyl derivative of creatinine (m/z 329) and from
— 0.25 to +0.25 mass units from the peak center of the
molecular ion of the derivative off13C,15Njcreatinme (m/z 332).
The exact position of the peak center with reference to the mass
calibration of the spectrometer is determined in a preliminary
run which is regularly carried out prior to a series of quantitative
measurements. The quadrupole filter of the mass spectrometer
repetitively scans each of tue two pre-adjusted mass ranges in
0.134s; the complete cycle takes about 0.280s. The intensity
Signals of the electron multipler of thfe spectrometer are recorded
on magnetic discs of a dedicated Computer System which is
integrated in the Finnigan mass spectrpmeter. The selected ion
chromatograms are displayed on a terminal for visual inspection
of the peaks and the Computer determines peak heights and
areas for the measurements at the two m/z-values.
Samples and Standards are injected alternately which makes it
possible to monitor the stability of the Instrumentation in the
course of an analytical series. A selected ion recording after
processing a serum sample is shown in figure 2.
Calculation Procedure
The results of the ID-MS determinations of ereatinine are
calculated from peak height or peak area ratios measured by
the selected ion monitoring technique. Since there is a mass
difference of 3 units between the non-labelled and the labelled
creatinine, the contribution of naturally occurring isotopes of
creatinine at m/z 332 is rather low. This results in an almost
linear function between the peak height or peak area ratios and
the amount of creatinine in samples and Standards. Furthermore
it should be noted that the labelled creatinine contains a very
small amount of less than 1% non-kbelled creatinine. Although
these alternate isotope contributions are rather small they are
taken into account by a calculation procedure which is reported
in detail in the first p per of the pfesent series on definitive
methods in clinical chemistry (23). , $
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Fig. 2. Selected ion recording (Computer print) of the trimethylsilyl derivative of creatinine (upper panel) and of [13C,]5N2]
crcatinine aftcr proccssing a serum sample. For cxpcrimental details see Materials and Proccd u re.
Accuracy
The accuracy of the method is ascertained by the
combination of two analytical principles: The isotope
dilution method which is applied here is the most
reliable procedure for monitoring recovery during
the analytical procedure. The second methodological
principle employed here is the selected ion monitoring
technique. At present, this method is generally
accepted s the most specific procedure for the meas-
urement of substances in a biological matrix. There-
fore, it may be assumed that the ID-MS technique,
which has also been elaborated in this laboratory for
the measurement of steroid hormones (23—25) and
uric acid (26), may also be successfuMy employed
for the highly accurate measurement of creatinine in
human serum.
Precision
The precision of the isotope dilution-mass
spectrometry measurement of creatinine in human
serum is determined by repetitive measurements of
the compound in several serum samples on different
occasions. For this purpose lyophilised control sera
which are distributed by the Deutsche Gesellschaft
f r Klinische Chemie for external quality control
are analysed on different occasions. The lyophilised
materials of 5 vials are reconstituted by addition of
distilled water; then the reconstituted sera are pooled
and frozen at — 20°C in portions of l ml. For each
analytical series one of these portions is thawed and
equilibrated to room temperature prior to analysis.
By this procedure any additional influence of a vial
to vial Variation between the lyophilised samples may
be excluded and only the method-dependent Standard
deviation is obtained. As shown in table l the coeffi-
cient of Variation is in a r nge from 0.32 to 1.04%.
Sensitivity
The combined gas chromatograph-mass spectrometer
is capable of recording 0.5 ng creatinine s tri-
methylsilyl derivative injected into the split inlet of
the System with a signal to noise ratio of 3:1. It
should be mentioned that more than the hundred-
fold amount is used in the analyses of serum samples.
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Tab. 1. Concentration of creatinine measured by ID-MS in















































































The concentration of creatinine in serum is one of
the most important clinical chemical parameters for
monitoring renal function. Much effort has been
devoted to the development of reliable methods for the
determination of the substance in clinical chemistry
(l -20). At present, a variety of methods employing
different analytical principles are in use in clinical
chemical laboratories. In external quality control it is
observed that, by using various methods for the analy-
sis of creatinine in the same serum sample, a scatter of
results is obtained which show more or less significant
discrepancies. For this reason it was necessary to
apply a variety of method-dependent target values in
external quality control in order to provide a fair basis
for the evaluation of the results of the participants in
collaborative surveys.
It therefore seems to be necessary to develop reference
and definitive methods for the measurement of cre-
atinine in human serum, by which the accuracy of the
routine methods may be critically judged. Moreover,
reference and definitive methods in future may provide
the most suitable basis for certifying target values for
collaborative surveys, thereby replacing the currently
used method-dependent assigned values.
In the present investigation a method was developed
which is based on the principle of isotope dilution-
mass spectrometry. It is generally accepted that this
technique, at present, provides one of the most specific
and accurate means for the measurement of chemical
substances in a complex biological matrix. Therefore,
the ID-MS technique has been used for the develop-
ment of several reference and definitive methods in
clinical chemistry which were reviewed by Tietz in
1979 (27). More recently the technique has been pro-
posed äs a reference or definitive method for the
measurement of cholesterol (28), Cortisol (23, 29, 30),
oestradiol-17ß (24, 25), uric acid (26) and thyroxine
(31). Björkhem and coworkers (l 8) rreported an ID-
MS method for the measurement of creatinine which
comprises the use of pNjIcreatinine äs internal Stan-
dard, extraction of creatinine with ethanol, puri-
fication of the samples by HPLC using gradient
elution, formation of a (2-hydroxy, 2-methyl)ethyl-di-
trifluoroacetate derivative in a two step reaction and
finally GC-MS using a packed SE-30 column.
In the present investigation, which aspires to the
development of a definitive method, the use of cre-
atinine äs a primary Standard material of high purity
is an imperative necessity. Fortunately, a certified
reference material was available from the National
Bureau of Standards, Washington, which fulfilled
these requirements. With fegard to the isotopically
labelled creatinine there was no preparatipn commer-
cially available which was suitable äs internal Standard
for ID-MS. Therefore it was necessary to synthe$ize
a labelled creatinine. It seemed to be advantageous
to make use of a compound which differs from the
non-labelled creatinine by at least 3 mass.units, since
the application of a material with a difference of oiily
2 mass units would result in a non-linear calibration
curve thereby restricting the possibility of precise
measurements to a small ränge of concentrations
of creatinine in the samples. Therefore a simple
preparative procedure stärting from labelled
cyanamide was elaborated which yields a labelled
creatinine containing one 13C- and two 15N-atoms.
This compound proved to be much more suitable for
internal standardization in selected ion monitoring äs
compared with the double labelled substance äs used
by Björkhem et. al. (18). After equilibration of the
labelled with the non-labelled creatinine the two
compounds were extracted from the serum samples
by the use of an ion exchamge resiü. By this very
simple procedure, applied here, several groups of
accompanying impurities from the biological matrix,
e.g. proteins and lipids, were removed from the
samples. Creatinine and the labelled analogue were
then converted into the tris-trimethylsilyl derivative,
which has already been described by Lawson in 1975
(32). The substance was easily prepared in a one^step-
reaction. As demonstrated from the mass spectra of
the creatinine derivative and that of the labelled
compound in figufe l, the molecular ions at m/z 329
and 332 show fairly high relative intensities after
electron impact ionisation. Therefore a sensitive de-
tection of the two substarices was fpossible when the
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combined GC-MS Instrument was run in the elcctron
impact ionisation mode. It was not necessary to use
alternative ionisation techniques such äs chemical
ionisation. When the reaction mixture, obtained after
processing a serum sample, was injeeted into the
Instrument which was adjusted to monitor m/z 329
and 332, only two peaks corresponding to the labelled
äs well äs the non-labelled creatinine derivative were
observed, äs shown in figure 2. This demonstrates
the high specificity of the selected ion monitoring
procedure. In addition a capillary gas chro-
matography column of high performance was coupled
to the mass spectrometer in order to separate any
compound from the biological matrix that possibly
could interfere with the detection of creatinine and
its labelled analogue, thereby increasing specificity
and accuracy of the method. For this reason, capillary
gas chromatography seemed to be advantageous äs
compared with other Separation methods e.g. high
performance liquid chromatography.
In order to calibrate the GC-MS Instrument for
quantitative analyses three Standards containing
different amounts of non-labelled creatinine were pre-
pared, encompassing the amount of the substance
in the serum samples; Standards and samples were
injeeted alternately into the GC-MS Instrument. As
already mentioned the contribution of naturally
occurring isotopes of the creatinine molecule to the
recording of the labelled creatinine is rather small
when using a threefold labelled analogue.
Nevertheless, this interference äs well äs the presence
of very small amounts of non-labelled creatinine in
the labelled internal Standard are taken into con-
sideration by applying a calibration function which
has been reported in detail in the first article of this
series (23).
Despite all efforts that have been devoted to the
development of highly accurate procedures for the
use äs definitive methods, there exists no final proof
of accuracy in general. With the creatinine method
described here there remain some very small sources
of possible error. These arc mainly due to the
uncertainty of the creatinine content (99.8%) in the
certified reference material which is less than 0.1 %. A
further source of possible systematic crror concerns
the balances and the accuracy of the calibrated test
weights which are used for weighing the creatinine
Standard material and for the calibration of the volu-
metric Instrumentation. The possible error due to this
uncertainty is estimated to be less than 0.2%. In
addition to the unknown systematic crrors the final
results of the analyses are affected from the im-
precision (0.32 to 1.04%, -coefficient of Variation)
which is mainly due to the instability of the isotope
ratio measurement with the mass spectrometer and to
the limited precision of measuring the volumes of
serum samples and Standard Solutions.
In conclusion it may be stated that, apart from a few
sources of unverifiable error, the procedure reported
here is capable of producing results which are äs
accurate äs possfble with reference to the present state
of technology. In view of the high specificity of the
selected ion monitoring technique and due to the exact
control of recovery employing the isotope dilution
principle, the profcedure reported here may be pro-
posed äs a definitive method for the measurement of
creatinine in human serum.
The method has been used for about two years for
the measurement of creatinine in the control sera
which were distributed for the collaborative surveys
of the Deutsche Gesellschaft für Klinische Chemie.
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